For Galvin, thats the real win
Dickman, R
Key timing considerations: Side effect profile tends to be somewhat milder than semaglutide, which may reduce the importance of sleep-through timing Same 48-hour minimum spacing rule applies if changing injection days Pre-filled pen format means no reconstitution time, making spontaneous timing adjustments easier Many dulaglutide users report minimal side effects after the first month, at which point timing becomes purely a convenience decision Retatrutide (weekly injectable, investigational) Dosing frequency: Once weekly Half-life: Data from Phase 2 trials suggest approximately 6 days Peak concentration: Approximately 24 to 72 hours after injection Recommended timing approach: As a triple agonist (GLP-1/GIP/glucagon), retatrutide may produce a different side effect profile than pure GLP-1 or dual GLP-1/GIP agonists

When to Seek Immediate Medical Attention Severe, persistent abdominal pain (possible pancreatitis) Vision changes or eye pain (possible retinopathy) Signs of severe dehydration (dizziness, dark urine, confusion) Allergic reaction (rash, difficulty breathing, swelling) Severe hypoglycemia (confusion, sweating, rapid heartbeat) Persistent vomiting lasting more than 24 hours GLP-1 drugs are being increasingly obtained by individuals without a prescription, which makes side effects more dangerous than ever